These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18045960)

  • 21. The role of ultrasound in thyroid nodules with a cytology reading of "suspicious for papillary thyroid carcinoma".
    Kwak JY; Kim EK; Kim MJ; Hong SW; Choi SH; Son EJ; Oh KK; Park CS; Chung WY; Kim KW
    Thyroid; 2008 May; 18(5):517-22. PubMed ID: 18407756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
    Romei C; Ciampi R; Faviana P; Agate L; Molinaro E; Bottici V; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
    Endocr Relat Cancer; 2008 Jun; 15(2):511-20. PubMed ID: 18509003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When fine-needle aspiration biopsy cannot exclude papillary thyroid cancer: a therapeutic dilemma.
    Mittendorf EA; Khiyami A; McHenry CR
    Arch Surg; 2006 Oct; 141(10):961-6; discussion 966. PubMed ID: 17043273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.
    Liu S; Gao A; Zhang B; Zhang Z; Zhao Y; Chen P; Ji M; Hou P; Shi B
    Exp Mol Pathol; 2014 Oct; 97(2):292-7. PubMed ID: 25111330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
    Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
    Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
    Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
    Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
    Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
    Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
    Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of fine-needle aspiration biopsy in the management of patients with thyroid nodules.
    Zagorianakou P; Malamou-Mitsi V; Zagorianakou N; Stefanou D; Tsatsoulis A; Agnantis NJ
    In Vivo; 2005; 19(3):605-9. PubMed ID: 15875783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of thyroid FNA material for routine cytology and BRAF testing: a validation study.
    Troncone G; Cozzolino I; Fedele M; Malapelle U; Palombini L
    Diagn Cytopathol; 2010 Mar; 38(3):172-6. PubMed ID: 19693938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of BRAF mutation on fine needle aspiration biopsy specimens: diagnostic and clinical implications for papillary thyroid cancer.
    Guo F; Hou P; Shi B
    Acta Cytol; 2010; 54(3):291-5. PubMed ID: 20518413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine needle aspiration biopsy of thyroid nodules in children and adolescents.
    Chang SH; Joo M; Kim H
    J Korean Med Sci; 2006 Jun; 21(3):469-73. PubMed ID: 16778391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.
    Meng Z; Lu J; Wu H; Zhao Y; Luo Y; Gao J; Zhu Q; Jiang Y; Li W; Liang Z
    Tumour Biol; 2016 Jan; 37(1):611-8. PubMed ID: 26240026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population.
    Kim SW; Lee JI; Kim JW; Ki CS; Oh YL; Choi YL; Shin JH; Kim HK; Jang HW; Chung JH
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3693-700. PubMed ID: 20501689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of B-RAF mutation in papillary carcinoma of the thyroid in north-east Italy.
    Girlando S; Cuorvo LV; Bonzanini M; Morelli L; Amadori P; Dalla Palma P; Barbareschi M
    Int J Surg Pathol; 2010 Jun; 18(3):173-6. PubMed ID: 20460314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mRNA BRAF expression helps to identify papillary thyroid carcinomas in thyroid nodules independently of the presence of BRAFV600E mutation.
    Araujo PP; Marcello MA; Tincani AJ; Guilhen AC; Morari EC; Ward LS
    Pathol Res Pract; 2012 Aug; 208(8):489-92. PubMed ID: 22770943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic value of fine needle aspiration cytology in thyroid swellings in a university hospital, Yemen.
    Al-Hureibi KA; Al-Hureibi AA; Abdulmughni YA; Aulaqi SM; Salman MS; Al-Zooba EM
    Saudi Med J; 2003 May; 24(5):499-503. PubMed ID: 12847625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of malignancy markers in thyroid nodules by reverse transcriptase polymerase chain reaction (RT-PCR)].
    Pineda P; Rojas P; Liberman C; Moyano L; Goecke I
    Rev Med Chil; 2003 Sep; 131(9):965-72. PubMed ID: 14635582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.
    Liu RT; Chen YJ; Chou FF; Li CL; Wu WL; Tsai PC; Huang CC; Cheng JT
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):461-6. PubMed ID: 16181240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of fine needle aspiration biopsy with and without the use of tumor markers in cytologically indeterminate thyroid lesions.
    Matesa N; Samija I; Kusić Z
    Coll Antropol; 2010 Mar; 34(1):53-7. PubMed ID: 20432733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.